Fibroblast growth factor 21 levels and liver inflammatory biomarkers in obese subjects after weight loss

INTRODUCTION: Previous studies have hypothesized fibroblast growth factor 21 (FGF-21) as a potential biomarker of the inflammation associated with liver diseases, which is also receiving considerable attention for its potential application concerning the management of obesity and co-morbidities. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantero, Irene, Abete, Itziar, Bullón-Vela, Vanessa, Crujeiras, Ana B., Casanueva, Felipe F., Zulet, M. Angeles, Martinez, J. Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826683/
https://www.ncbi.nlm.nih.gov/pubmed/35154523
http://dx.doi.org/10.5114/aoms/98948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826683/
https://www.ncbi.nlm.nih.gov/pubmed/35154523
http://dx.doi.org/10.5114/aoms/98948

Ejemplares similares